Roel Bogie

Endoscopic subtypes of colorectal laterally spreading tumors and risk of submucosal invasion: A meta-analysis

Nosho 2008 • • • • R Therapy (all) FAP, Lynch syndrome NA Mean 67 57.9% Kudo 2008 • • • • P Therapy (?) NA 22 NA NA (SD 10.4) 70.1%

Kaltenbach 2007 • º • R Therapy (EMR) NA 5 NA NA 61.1%

Uraoka 2006 • • • • • R Therapy (all) FAP, IBD, precious history of CRC 4 NA NA syndrome 21/2 Mean 62.5 (SD 13.3) 66*

67.9%

61.7%

72.4%

3 Tsuda 2002 • • º • P All indications FAP, IBD, Lynch Tanaka 2001 • • •/ º P Therapy (all), LSTs ≥20mm NA NA NA NA Saito 2001 • • • R Therapy (all) NA 101/2 Mean 65 59.9% colonoscopies 67.5* 50.7%

54.5*

60.6*

Kil Lee 2008 • º • P All indications NA 7 Mean 58.7

Parra-Blanco 2006 • • • • º • R All indications FAP, IBD, Lynch Katsinelos 2006 • • • • • R Therapy (EMR, surgery) NA 8 Mean 66.5 38.1% Hiraoka 2006 • • • P Therapy (EMR, surgery FAP, IBD, Lynch Syndrome 11/2 Median Su 2005 • • • R Therapy (EMR) NA 3 Mean O'Brien 2004 Therapy (all) FAP, IBD, • • º • R

91/2 Mean 62 73.0%

Kim 2003 • • • º • R All indications NA 51/2 Mean syndrome 2 Mean

33/4 Mean 59 41.2%

history or CRC or previous

polypectomy

Rembacken 2000 • º • P All indications Incomplete

Table 3.1: (continuation)

47